Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator-Reference-Cited by-同舟云学术

Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator

Published:2012-02-13 Issue:4 Volume:7 Page:672-677
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Kumar Naresh¹,Lyda Brent¹,Chang Mi Ra¹,Lauer Janelle L.¹,Solt Laura A.¹,Burris Thomas P.¹,Kamenecka Theodore M.¹,Griffin Patrick R.¹

Affiliation:

1. Department of Molecular Therapeutics, The Scripps Research Molecular Screening Center (SRMSC), The Scripps Research Institute, Scripps Florida, Jupiter, Florida 33458, United States

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/cb200496y

Reference15 articles.

1. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells

2. Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice

4. T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ

5. Structural Basis for Hydroxycholesterols as Natural Ligands of Orphan Nuclear Receptor RORγ

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunology of bile acids regulated receptors;Progress in Lipid Research;2024-07

2. Agonists, inverse agonists, and antagonists as therapeutic approaches to manipulate retinoic acid-related orphan receptors;Canadian Journal of Physiology and Pharmacology;2024-05-10

3. Discovery and pharmacological characterization of 1,2,3,4-tetrahydroquinoline derivatives as RORγ inverse agonists against prostate cancer;Acta Pharmacologica Sinica;2024-05-02

4. Screening, Deconvolution and Parallel Synthesis of Trisubstituted Piperazine and Trisubstituted 2,3-diketopierazine Libraries for the Rapid Identification of Antagonists of the Nuclear Retinoic Acid Receptor-related Orphan Receptor Gamma (RORγ);Letters in Drug Design & Discovery;2024-04

5. Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer;Journal of Medicinal Chemistry;2024-01-16